首页> 外文期刊>Virology >Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.
【24h】

Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.

机译:密码子优化的SARS相关冠状病毒刺突蛋白中的小鼠CD8 T细胞表位的鉴定。

获取原文
获取原文并翻译 | 示例
           

摘要

The causative agent of severe acute respiratory syndrome (SARS) has been identified as a new type of coronavirus, SARS-associated coronavirus (SARS-CoV). CD8 T cells play an important role in controlling diseases caused by other coronaviruses and in mediating vaccine-induced protective immunity in corresponding animal models. The spike protein, a main surface antigen of SARS-CoV, is one of the most important antigen candidates for vaccine design. Overlapping peptides were used to identify major histocompatibility complex class I-restricted epitopes in mice immunized with vectors encoding codon-optimized SARS-CoV spike protein. CD8 T-cell responses were mapped to two H-2(b)-restricted epitopes (S436-443 and S525-532) and one H-2(d)-restricted epitope (S366-374). The identification of these epitopes will facilitate the evaluation of vaccine strategies in murine models of SARS-CoV infection. Furthermore, codon and promoter optimizations can greatly enhance the overall immunogenicity of spike protein in the context of replication-defective human and simian adenoviral vaccine carriers. The optimized recombinant adenoviral vaccine vectors encoding spike can generate robust antigen-specific cellular immunity in mice and may potentially be useful for control of SARS-CoV infection.
机译:严重急性呼吸综合征(SARS)的病原已被鉴定为一种新型冠状病毒,即SARS相关冠状病毒(SARS-CoV)。 CD8 T细胞在控制其他冠状病毒引起的疾病和介导疫苗诱导的相应动物模型的保护性免疫中起重要作用。刺突蛋白是SARS-CoV的主要表面抗原,是疫苗设计中最重要的候选抗原之一。重叠的肽用于鉴定用编码密码子优化的SARS-CoV穗突蛋白的载体免疫的小鼠中主要的组织相容性复合体I类限制性表位。 CD8 T细胞反应被映射到两个H-2(b)限制性表位(S436-443和S525-532)和一个H-2(d)限制性表位(S366-374)。这些表位的鉴定将有助于评估SARS-CoV感染的鼠模型中的疫苗策略。此外,在复制缺陷型人和猿猴腺病毒疫苗载体的情况下,密码子和启动子的优化可以大大增强刺突蛋白的整体免疫原性。编码刺突的优化重组腺病毒疫苗载体可以在小鼠中产生强大的抗原特异性细胞免疫,并可能潜在地用于控制SARS-CoV感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号